Skip to main content
. 2016 Sep 1;2016(9):CD011440. doi: 10.1002/14651858.CD011440.pub2

1.11. Analysis.

1.11

Comparison 1 Asthma treatment tailored on FeNO versus clinical symptoms, Outcome 11 Subgroup (control guideline use): Number of exacerbations per 52 weeks (exacerbation rates).